Bio Basic

What Bio Basic does

Bio Basic Inc. is a privately held Canadian life science research support company founded in 2004 and headquartered in Markham, Ontario, with a secondary office in Amherst, New York. The company operates a dual CRO/CMO model: it delivers fee-for-service custom synthesis and analytical work — gene synthesis (up to 25kb+ with >95% completion), oligo synthesis (with its patented High Affinity Purification process), DNA sequencing (Sanger and NGS), peptide synthesis (including GMP grade), recombinant protein production across multiple expression systems, and monoclonal/polyclonal antibody production — alongside a broad catalog of molecular biology kits, PCR reagents, culture media, biochemicals, labware, electrophoresis supplies, benchtop equipment, antibiotics, premade proteins, GMP-grade products, and CE-IVD certified diagnostic kits. Customers span academic and university research labs, pharmaceutical and biotechnology firms, clinical and diagnostic laboratories, and a global distributor network, served through direct e-commerce storefronts, OEM/white-label partnerships, physical Bio Bars/Central Stores, and the Scientist.com marketplace.

The technology stack centers on DNA/RNA synthesis methodologies — solid-phase synthesis, chip-based parallel gene synthesis for cost-efficient scale, and PCR-based enzyme synthesis — supplemented by proprietary enzymes and reagents that the company says drive higher success rates on complex genes. The published pricing model is transparent unit pricing with no hidden fees: gene synthesis starts at a $99 minimum, oligos at $6.00 for HPLC-purified product, and custom services are quote-based with clear turnaround commitments (e.g., 18-24 business days for gene synthesis, 24-48 hours for Sanger sequencing). The go-to-market is sales-led, combining self-service e-commerce for SMB/individual researchers with sales-team outreach to pharma/biotech and OEM enterprise accounts.

Bio Basic is privately held with no disclosed funding, parent company, or institutional investors, and appears founder-operated. Quality posture is anchored by ISO 9001:2015 certification and CE-IVD marking on its diagnostic kits; GMP-grade offerings (powders, buffers, cell culture media, WFI water, BSA, peptides) open the door to pharmaceutical-manufacturing supply chains. The company is consistently cited as a key player in third-party market research covering the $17.3B global molecular biology enzymes market alongside Thermo Fisher, Merck KGaA, Illumina, QIAGEN, Promega, Roche, and GenScript, indicating maintained relevance in a market dominated by far larger incumbents.

Name

Bio Basic

Legal name

Bio Basic Inc.

Website

https://biobasic.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Bio Basic Inc. is a Canadian life science CRO/CMO founded in 2004 that provides custom gene, oligo, peptide, protein, and antibody synthesis, DNA sequencing, and a catalog of molecular biology kits, biochemicals, labware, and benchtop equipment to academic, pharmaceutical, and biotechnology customers across North America and globally.

Ownership category

akta.pro rank

Product category

Life Science Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

akta.pro secondary industries

Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

Keywords

• Gene synthesis services
• Oligonucleotide synthesis
• Peptide synthesis services
• Recombinant protein production
• Molecular biology reagents

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Research Products Sales: Sale of molecular biology products including biochemicals, culture media, labware, electrophoresis supplies, PCR reagents, molecular biology kits, and benchtop equipment through e-commerce platform
2. Gene Synthesis Services: Custom gene synthesis, subcloning, and mutagenesis services with pricing based on sequence length and complexity, minimum price $99 per gene
3. Oligo Synthesis Services: Custom oligonucleotide synthesis starting at $6.00/oligo for HPLC purification, with various purification options and modifications
4. DNA Sequencing Services: Sanger DNA sequencing and Next-Generation Sequencing services with turnaround times of 24-48 hours
5. Peptide Synthesis Services: Custom peptide synthesis including cosmetic peptides, pharmaceutical peptides, and GMP peptides
6. Protein Production Services: Recombinant protein production using multiple expression systems (E.coli, Baculovirus, Mammalian, Yeast) with purification and characterization
7. Antibody Production Services: Monoclonal and polyclonal antibody production services with guaranteed titers
8. Diagnostic Products: COVID-19 detection kits, RT-PCR reagents, and CE-IVD certified diagnostic products
9. GMP Products: GMP-grade powders, buffers, cell culture media, water for injection (WFI), BSA, and peptides for pharmaceutical manufacturing

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

Bio Basic manufactures and sells life science research products including molecular biology kits, biochemicals, labware, PCR reagents, electrophoresis supplies, culture media, and benchtop equipment, while operating as both a Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) providing custom fee-for-service synthesis and sequencing capabilities such as gene synthesis, oligo synthesis, peptide synthesis, protein production, antibody production, and DNA sequencing (Sanger and NGS). The company also supplies GMP-grade powders, buffers, cell culture media, WFI water, BSA, peptides, and CE-IVD certified diagnostic products for pharmaceutical and clinical research customers.

Product overview

Bio Basic is a life science research support company offering a comprehensive portfolio of products and services for molecular biology, biotechnology, and pharmaceutical research. The company operates as both a Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO), providing fee-for-service synthesis capabilities alongside a catalog of laboratory products. Core services include Gene Synthesis (supporting genes up to 25kb+), Oligo Synthesis, DNA Sequencing (Sanger and NGS), Peptide Synthesis, Protein Production, and Antibody Production. The product catalog spans Molecular Biology Kits, PCR Reagents, Culture Media, Biochemicals, Labware, Electrophoresis Supplies, Benchtop Equipment, Antibiotics, Premade Proteins, and COVID-19 Diagnostics. GMP-grade products are offered for pharmaceutical manufacturing applications. The company serves academic institutions, pharmaceutical companies, and biotechnology firms across North America.

Differentiator

Problem solved

Functional benefit

Brands

• Bio Bar: A physical storefront concept offered at customer locations for convenient access to Bio Basic products and services.
• Gene Order Portal

Products and services

• Gene Synthesis

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered minor.

• Thermo Fisher ScientificminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market ($17.3B market size in 2025). Both companies compete in providing molecular biology research tools and services.
• Merck KGaAminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market. Both companies compete in providing molecular biology research tools and services.
• IlluminaminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market. Both companies serve the genomics and sequencing market.
• QIAGENminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market. Both companies provide molecular biology kits and reagents.
• Promega CorporationminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market. Both companies compete in providing molecular biology research products.
• F. Hoffmann-La Roche LtdminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market.
• GenScript BiotechminorOthersListed alongside Bio Basic as a key player in the global molecular biology enzymes market. Both companies provide gene synthesis and molecular biology services.
• Scientist.comminorChannel Partner/ Reseller/ DistributorBio Basic is a registered supplier on the Scientist.com marketplace platform, which connects researchers with suppliers of research products and services.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Boster Bio: Boster Bio provides antibodies, ELISA kits, and molecular biology reagents to academic and biotech researchers — an emerging player with partial overlap to Bio Basic's antibody production and reagent catalog businesses.

Direct peers

• Twist Bioscience: Twist Bioscience is a leading DNA synthesis company using silicon-based platform technology for gene and oligo synthesis at scale — directly competing with Bio Basic in gene synthesis while leveraging more capital-intensive production technology.
• ProteoGenix: ProteoGenix specializes in recombinant protein expression, antibody production, and peptide synthesis — directly comparable to Bio Basic's protein and antibody service offerings for biotech and pharmaceutical customers.
• Synbio Technologies: Synbio Technologies offers custom gene synthesis, oligo synthesis, and molecular biology services with competitive pricing — closely mirroring Bio Basic's value proposition and customer segments in the global research tools market.
• GenScript Biotech: GenScript is a global life science CRO/CDMO offering gene synthesis, oligo synthesis, peptide synthesis, and protein production — directly overlapping with Bio Basic's core service portfolio and serving the same academic and biotech customer base.
• Biomatik: Biomatik provides custom peptide synthesis, protein production, and antibody services — directly overlapping with Bio Basic's peptide and protein service lines while also offering gene synthesis to academic and biotech customers.
• Eurofins Genomics: Eurofins Genomics provides gene synthesis, oligo synthesis, Sanger/NGS sequencing, and molecular biology services to research customers worldwide — directly comparable to Bio Basic's CRO service offerings with similar customer targeting.

Broad incumbents

• Integrated DNA Technologies (IDT): IDT (a Danaher company) is a major oligo and gene synthesis provider serving research and diagnostics markets globally — competing directly in Bio Basic's core oligo synthesis segment but at substantially larger scale and broader product scope.
• Thermo Fisher Scientific: Thermo Fisher is a global life science tools leader offering gene synthesis, oligo manufacturing, molecular biology reagents, and CDMO services — a broader incumbent that overlaps with Bio Basic across multiple product and service categories.
• Promega Corporation: Promega manufactures molecular biology reagents, PCR products, and protein expression systems serving research and clinical diagnostics — overlapping with Bio Basic's reagent catalog and serving similar academic/biotech customers.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/biobasicinc
• Facebookfacebook.com/biobasic.inc
• LinkedInlinkedin.com/company/bio-basic-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio Basic